Notice - Multicounty Litigation Application - New Jersey State Court Litigation Involving Bard Implanted Port Catheter Products – Comments/Objections Due June 21, 2024

The Supreme Court has received a second application pursuant to Directive #02-19, "Multicounty Litigation Guidelines and Criteria for Designation (Revised)," for Multicounty Litigation (MCL) designation of New Jersey state-court litigation against C.R. Bard Inc., Bard Access Systems Inc., and Becton Dickinson and Company alleging injuries as a result of the use of Bard Implanted Port Catheter Products. The Court denied a previous application due to the limited number of cases filed at that time.

This MCL application was submitted by counsel for plaintiffs.

Anyone wishing to comment on or object to this application should provide such comments or objections in writing, with relevant supporting documentation, by June 21, 2024 to:

Glenn A. Grant, J.A.D.
Acting Administrative Director of the Courts
Attn: MCL Application - Bard Implanted Port Catheter Products
Hughes Justice Complex, P.O. Box 037
Trenton, New Jersey 08625-0037
Comments/objections may also be submitted by email to Comments.mailbox@njcourts.gov.

A copy of the application submitted to the Court is posted with this Notice on the Judiciary's Internet Website at (www.njcourts.gov) in the Multicounty Litigation Information Center https://www.njcourts.gov/attorneys/multicounty-litigation.